Signaling Pathways - CK2 - Insulin and Insulin-like Receptors - 5-HT receptors - c-Fms tyrosine kinase
清除全部
- B2249 Lamotrigine1 Citation中文名: 拉莫三嗪Target: 5-HT receptors|sodium channelSummary: 5-HT抑制剂,钠通道阻断剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3894 TTP 221 CitationTarget: CK2Summary: CK2抑制剂
- A3861 TBB1 CitationTarget: CK2Summary: 酪蛋白激酶-2(CK2)抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3527 Ki20227Target: c-Fms tyrosine kinaseSummary: C-Fms酪氨酸激酶抑制剂
- A3392 Emodin中文名: 大黄素Target: CK2Summary: 天然存在的蒽醌,抗增殖
- A3368 DMAT2 CitationTarget: Pim|CK2|HIPK2|HIPK3Summary: CK2抑制剂